Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Entera Bio (ENTX) Non-cash Items (2019 - 2021)

Entera Bio has reported Non-cash Items over the past 3 years, most recently at $10.7 million for Q2 2021.

  • For the quarter ending Q2 2021, Non-cash Items rose 1724.66% year-over-year to $10.7 million, compared with a TTM value of $10.7 million through Jun 2021, up 1724.66%, and an annual FY2018 reading of $1.0 million, down 82.01% over the prior year.
  • Non-cash Items came in at $10.7 million for Q2 2021, up from $584000.0 in the prior quarter.
  • In the past five years, Non-cash Items ranged from a high of $10.7 million in Q2 2021 to a low of $76000.0 in Q2 2019.
  • Median Non-cash Items over the past 3 years was $584000.0 (2020), compared with a mean of $3.8 million.
  • The sharpest move saw Non-cash Items surged 668.42% in 2020, then soared 1724.66% in 2021.
  • Over 3 years, Non-cash Items stood at $76000.0 in 2019, then surged by 668.42% to $584000.0 in 2020, then soared by 1724.66% to $10.7 million in 2021.
  • Per Business Quant, the three most recent readings for ENTX's Non-cash Items are $10.7 million (Q2 2021), $584000.0 (Q2 2020), and $76000.0 (Q2 2019).